Delirium in patients with advanced cancer

Hematology/Oncology Clinics of North America

Volumn 16, Issue 3, 2002, Pages 701-714

  Lawlor, Peter G ^a,b   Bruera, Eduardo D ^c,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GREY NUNS COMMUNITY HOSPITAL   (Canada)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; OLANZAPINE; RISPERIDONE;

ADVANCED CANCER; BEHAVIOR; DELIRIUM; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE PERSONNEL; HUMAN; MEDICAL ETHICS; PHENOMENOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TERMINAL CARE; CANCER STAGING; CONSCIOUS SEDATION; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; FAMILY; HOSPITALIZATION; INTERPERSONAL COMMUNICATION; MASS SCREENING; METHODOLOGY; NEOPLASM; PALLIATIVE THERAPY; PATIENT ADVOCACY; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; STANDARD;

CAUSALITY; COMMUNICATION; CONSCIOUS SEDATION; DELIRIUM; DIAGNOSIS, DIFFERENTIAL; ETHICS, MEDICAL; EVIDENCE-BASED MEDICINE; FAMILY; HUMAN; MASS SCREENING; NEOPLASM STAGING; NEOPLASMS; PALLIATIVE CARE; PATIENT ADVOCACY; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX; HUMANS;

EID: 0036021434     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(02)00021-7     Document Type: Review

References (84)

1. Occurrence, causes, and outcome of delirium in advanced cancer patients: A prospective study
2. Psychiatric aspects of palliative care
3. Delirium in the elderly patient
4. Delirium (acute confusional states)
5. Delirium in the older person with cancer
6. Psychiatric morbidity in terminally ill cancer patients. A prospective study
7. Cognitive failure in patients with terminal cancer: A prospective study
8. The frequency and clinical course of cognitive impairment in patients with terminal cancer
9. Delirium in terminally ill cancer patients
10. Risk factors for delirium in hospitalized elderly
11. Acute confusional states in elderly patients treated for femoral neck fracture
12. A prospective study of delirium in hospitalized elderly
13. Predicting delirium in elderly patients: Development and validation of a risk-stratification model
14. Aging and cancer in America: Demographic and epidemiologic perspectives
15. Cancer in the frail patient. A coming epidemic
16. Introduction: Critical issues in the assessment of delirium
17. Delirium at the end of life: Critical issues in clinical practice and research
18. Misdiagnosing delirium as depression in medically ill elderly patients
19. The misdiagnosis of delirium
20. Delirium presenting with symptoms of depression
21. Underdiagnosis and poor documentation of acute confusional states in elderly hip fracture patients
22. The dilemma of delirium: Clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients
23. Delirium and dementia; are they distinct?
24. The use of environmental strategies and psychotropic medication in the management of delirium
25. Delirium, dementia and amnestic and other cognitive disorders
26. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer
27. The importance of recognizing and measuring delirium
28. Symptom control: The problem areas
29. Palliative care: An update on "terminal restlessness"
30. Development of an instrument to measure terminal restlessness
31. Delirium in cancer patients
32. Delirium
33. A critique of instruments and methods to detect, diagnose, and rate delirium
34. Review of research instruments and techniques used to detect delirium
35. Cognitive screening instruments in neuropsychiatry: A report of the Committee on Research of the American Neuropsychiatric Association
36. A review of delirium assessment instruments
37. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
38. Clarifying confusion: The confusion assessment method. A new method for detection of delirium
39. Delirium in terminal cancer: A prospective study using daily screening, early diagnosis, and continuous monitoring
40. The Memorial Delirium Assessment Scale
41. Clinical utility, factor analysis and further validation of the Memorial Delirium Assessment Scale (MDAS) in advanced cancer patients
42. The assessment of pain intensity in patients with cognitive failure: A preliminary report
43. Counseling the confused patient and the family
44. Revisiting the O complex: Urinary incontinence, delirium and polypharmacy in elderly patients
45. Clinical significance of delirium subtypes in older people
46. When to treat dehydration in a terminally ill patient?
47. Delirium as a contributing factor to "crescendo" pain: Three case reports
48. Delirium impacts on the circadian pattes of breakthrough analgesia in advanced cancer patients
49. A perspective on the management of delirium in terminally ill patients on a palliative care unit
50. Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence
51. The impact of delirium on the expression of pain and other symptoms in advanced cancer patients
52. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics
53. Delirium risk factors in elderly hospitalized patients
54. Identification of factors associated with the diagnosis of delirium in elderly hospitalized patients
55. Delirium in hospitalized older persons: Outcomes and predictors
56. A prospective multicenter assessment of the Edmonton Staging System for cancer pain
57. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability
58. Subsyndromal delirium
59. A multicomponent intervention to prevent delirium in hospitalized older patients
60. Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation
61. Side-effects of opioids in chronic pain treatment
62. Opioid rotation for toxicity reduction in terminal cancer patients
63. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone
64. Altered mental status in patients with cancer
65. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients
66. Defining palliative care interventions
67. Symptom control during the last week of life on a palliative care unit
68. Epidemiology and clinical features of delirium
69. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients
70. Treatment of delirium at the end of life: Medical and ethical issues
71. Sedation for intractable distress in the dying - A survey of experts
72. Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment
73. Symptom prevalence and control during cancer patients' last days of life
74. Sedation for uncontrolled symptoms in a South African hospice
75. Sedation for symptom control in Japan: The importance of intermittent use and communication with family members
76. A comparison of the use of sedatives in a hospital support team and in a hospice
77. A multi-centre international study of sedation for uncontrolled symptoms in terminally ill patients
78. Commentary: A case of "terminal sedation" in the family
79. Commentary: Sedation in response to refractory existential distress: Walking the fine line
80. The terminal phase
81. Terminal restlessness - Its management and the role of midazolam
82. The role of double effect - A critique of its role in end-of-life decision making